James M Mock Moderna, Inc. (MRNA) insider trading activity

James M Mock is Chief Financial Officer of Moderna, Inc.. Currently has a direct ownership of 16,191 shares of MRNA, which is worth approximately $413,680. The most recent transaction as insider was on May 28, 2025, when has been sold 159 shares (Common Stock) at a price of $26.76 per share, resulting in proceeds of $4,254. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.2K

8.85% 3M change

148.86% 12M change

Total Value Held $413,680

James M Mock Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 28 2025	SELL Payment of exercise price or tax liability	$4,254 $26.76 p/Share	159 Reduced 0.97%	16,191 Common Stock
May 28 2025	BUY Exercise of conversion of derivative security	-	328 Added 1.97%	16,350 Common Stock
May 27 2025	SELL Payment of exercise price or tax liability	$9,821 $26.26 p/Share	374 Reduced 2.28%	16,022 Common Stock
May 27 2025	BUY Exercise of conversion of derivative security	-	773 Added 4.5%	16,396 Common Stock
Apr 04 2025	SELL Payment of exercise price or tax liability	$18,088 $25.73 p/Share	703 Reduced 4.31%	15,623 Common Stock
Apr 04 2025	BUY Exercise of conversion of derivative security	-	1,452 Added 8.17%	16,326 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$4,974 $31.09 p/Share	160 Reduced 1.06%	14,874 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	329 Added 2.14%	15,034 Common Stock
Feb 27 2025	SELL Payment of exercise price or tax liability	$93,352 $33.58 p/Share	2,780 Reduced 15.9%	14,705 Common Stock
Feb 27 2025	BUY Exercise of conversion of derivative security	-	5,746 Added 27.24%	15,347 Common Stock
Jan 03 2025	SELL Payment of exercise price or tax liability	$32,760 $42.0 p/Share	780 Reduced 6.23%	11,739 Common Stock
Jan 03 2025	BUY Exercise of conversion of derivative security	-	1,453 Added 10.4%	12,519 Common Stock
Nov 29 2024	SELL Open market or private sale	$60,761 $42.79 p/Share	1,420 Reduced 11.37%	11,066 Common Stock
Nov 27 2024	BUY Exercise of conversion of derivative security	-	2,981 Added 19.27%	12,486 Common Stock
Oct 07 2024	SELL Open market or private sale	$42,985 $60.12 p/Share	715 Reduced 7.0%	9,505 Common Stock
Oct 04 2024	BUY Exercise of conversion of derivative security	-	1,453 Added 12.45%	10,220 Common Stock
Aug 29 2024	SELL Open market or private sale	$12,640 $78.03 p/Share	162 Reduced 1.81%	8,767 Common Stock
Aug 28 2024	SELL Open market or private sale	$104,874 $79.39 p/Share	1,321 Reduced 13.32%	8,600 Common Stock
Aug 28 2024	BUY Exercise of conversion of derivative security	-	329 Added 3.55%	8,929 Common Stock
Aug 27 2024	BUY Exercise of conversion of derivative security	-	2,652 Added 21.09%	9,921 Common Stock
Jul 08 2024	SELL Open market or private sale	$81,467 $118.24 p/Share	689 Reduced 8.66%	7,269 Common Stock
Jul 05 2024	BUY Exercise of conversion of derivative security	-	1,452 Added 15.43%	7,958 Common Stock
Jun 03 2024	SELL Open market or private sale	$97,237 $140.72 p/Share	691 Reduced 9.6%	6,506 Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	-	1,326 Added 15.56%	7,197 Common Stock
May 29 2024	SELL Open market or private sale	$26,443 $144.5 p/Share	183 Reduced 3.02%	5,871 Common Stock

Also insider at

PKI

PERKINELMER INC Healthcare

Officer

JMM

James M Mock

Chief Financial Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account